1
|
Cho H, Blatchley MR, Duh EJ and Gerecht S:
Acellular and cellular approaches to improve diabetic wound
healing. Adv Drug Deliver Rev. 146:267–288. 2019.
|
2
|
Jones RE, Foster DS and Longaker MT:
Management of chronic wounds-2018. JAMA. 320:1481–1482.
2018.PubMed/NCBI
|
3
|
Bucala R, Spiegel LA, Chesney J, Hogan M
and Cerami A: Circulating fibrocytes define a new leukocyte
subpopulation that mediates tissue repair. Mol Med. 1:71–81.
1994.PubMed/NCBI
|
4
|
Chen D, Zhao Y, Li Z, Shou K, Zheng X, Li
P, Qi B and Yu A: Circulating fibrocyte mobilization in negative
pressure wound therapy. J Cell Mol Med. 21:1513–1522.
2017.PubMed/NCBI
|
5
|
Li J, Tan H, Wang X, Li Y, Samuelson L, Li
X, Cui C and Gerber DA: Circulating fibrocytes stabilize blood
vessels during angiogenesis in a paracrine manner. Am J Pathol.
184:556–571. 2014.PubMed/NCBI
|
6
|
Hartlapp I, Abe R, Saeed RW, Peng T,
Voelter W, Bucala R and Metz CN: Fibrocytes induce an angiogenic
phenotype in cultured endothelial cells and promote angiogenesis in
vivo. FASEB J. 15:2215–2224. 2001.PubMed/NCBI
|
7
|
Chen Z, Meng P, Li HT, Li M, Yang LF, Yan
Y, Li YT, Zou XL, Wang DY and Zhang TT: Thymic stromal
lymphopoietin contribution to the recruitment of circulating
fibrocytes to the lung in a mouse model of chronic allergic asthma.
J Asthma. 55:975–983. 2018.PubMed/NCBI
|
8
|
Isgrò M, Bianchetti L, Marini MA, Bellini
A, Schmidt M and Mattoli S: The C-C motif chemokine ligands CCL5,
CCL11, and CCL24 induce the migration of circulating fibrocytes
from patients with severe asthma. Mucosal Immunol. 6:718–727.
2013.PubMed/NCBI
|
9
|
Liu Y, Qingjuan S, Gao Z, Deng C, Wang Y
and Guo C: Circulating fibrocytes are involved in inflammation and
leukocyte trafficking in neonates with necrotizing enterocolitis.
Medicine (Baltimore). 96:e74002017.PubMed/NCBI
|
10
|
Aono Y, Kishi M, Yokota Y, Azuma M,
Kinoshita K, Takezaki A, Sato S, Kawanoh, Kishi J, Gotoh, et al:
Role of platelet-derived growth factor/platelet-derived growth
factor receptor axis in the trafficking of circulating fibrocytes
in pulmonary fibrosis. Am J Resp Cell Mol. 51:793–801. 2014.
|
11
|
Xueyong L, Shaozong C, Wangzhou L, Yuejun
L, Xiaoxing L, Jing L, Yanli W and Jinqing L: Differentiation of
the pericyte in wound healing: The precursor, the process, and the
role of the vascular endothelial cell. Wound Repair Regen.
16:346–355. 2008.PubMed/NCBI
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI
|
13
|
Sambrook J and Russell DW:
Calcium-phosphate-mediated transfection of cells with
high-molecular-weight genomic DNA. Cold Spring Harbor Protoc.
2006:pdb.prot3872. 2006.
|
14
|
Smadja DM, Dorfmüller P, Guerin CL, Bieche
I, Badoual C, Boscolo E, Kambouchner M, Cazes A, Mercier O, Humbert
M, et al: Cooperation between human fibrocytes and endothelial
colony-forming cells increases angiogenesis via the CXCR4 pathway.
Thromb Haemostasis. 112:1002–1013. 2014.
|
15
|
Yamamoto T, Kawada K, Itatani Y, Inamoto
S, Okamura R, Iwamoto M, Miyamoto E, Chen-Yoshikawa TF, Hiraih,
Hasegawa S, et al: Loss of SMAD4 promotes lung metastasis of
colorectal cancer by accumulation of CCR1+
Tumor-associated neutrophils through CCL15-CCR1 axis. Clin Cancer
Res. 23:833–844. 2017.PubMed/NCBI
|
16
|
Inamoto S, Itatani Y, Yamamoto T,
Minamiguchi S, Hiraih, Iwamoto M, Hasegawa S, Taketo mM, Sakai Y
and Kawada K: Loss of SMAD4 promotes colorectal cancer progression
by accumulation of myeloid-derived suppressor cells through the
CCL15-CCR1 chemokine axis. Clin Cancer Res. 22:492–501.
2016.PubMed/NCBI
|
17
|
Singh SR, Sutcliffe A, Kaur D, Gupta S,
Desai D, Saunders R and Brightling CE: CCL2 release by airway
smooth muscle is increased in asthma and promotes fibrocyte
migration. Allergy. 69:1189–1197. 2014.PubMed/NCBI
|
18
|
Ishida Y, Kimura A, Nosaka M, Kuninaka Y,
Hemmih, Sasaki I, Kaisho T, Mukaida N and Kondo T: Essential
involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced
pulmonary fibrosis via regulation of fibrocyte and M2 macrophage
migration. Sci Rep. 7:168332017.PubMed/NCBI
|
19
|
Bian Y, Du Y, Wang R, Chen N, Du X, Wang Y
and Yuan H: A comparative study of HAMSCs/HBMSCs transwell and
mixed coculture systems. IUBMB Life. 71:1048–1055. 2019.PubMed/NCBI
|
20
|
Zhang C, Barrios MP, Alani RM, Cabodi M
and Wong JY: A microfluidic transwell to study chemotaxis. Exp Cell
Res. 342:159–165. 2016.PubMed/NCBI
|
21
|
Hwang J, Kim CW, Son KN, Han KY, Lee KH,
Kleinman HK, Ko J, Na DS, Kwon BS, Gho YS and Kim J: Angiogenic
activity of human CC chemokine CCL15 in vitro and in vivo. FEBS
Lett. 570:47–51. 2004.PubMed/NCBI
|
22
|
Park KH, Lee TH, Kim CW and Kim J:
Enhancement of CCL15 expression and monocyte adhesion to
endothelial cells (ECs) after hypoxia/reoxygenation and induction
of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs. J
Immunol. 190:6550–6558. 2013.PubMed/NCBI
|
23
|
Liu LZ, Zhang Z, Zheng BH, Shi Y, Duan M,
Ma LJ, Wang ZC, Dong LQ, Dong PP, Shi JY, et al: CCL15 recruits
suppressive monocytes to facilitate immune escape and disease
progression in hepatocellular carcinoma. Hepatology. 69:143–159.
2019.PubMed/NCBI
|
24
|
Harris DA: Inhibiting CXCL12 blocks
fibrocyte migration and differentiation and attenuates
bronchiolitis obliterans in a murine heterotopic tracheal
transplant model. J Thoracic Cardiovasc Surg. 145:854–861.
2013.
|